U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 203844

Expand all

RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
EQ 1.5MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 1.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203844
Product Number: 001
Approval Date: Feb 13, 2017
Applicant Holder Full Name: CADILA PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
EQ 3MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203844
Product Number: 002
Approval Date: Feb 13, 2017
Applicant Holder Full Name: CADILA PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
EQ 4.5MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 4.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203844
Product Number: 003
Approval Date: Feb 13, 2017
Applicant Holder Full Name: CADILA PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)
EQ 6MG BASE
Marketing Status: Prescription
Active Ingredient: RIVASTIGMINE TARTRATE
Proprietary Name: RIVASTIGMINE TARTRATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203844
Product Number: 004
Approval Date: Feb 13, 2017
Applicant Holder Full Name: CADILA PHARMACEUTICALS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top